Detalles de la búsqueda
1.
Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors.
JTO Clin Res Rep
; 4(4): 100482, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37090101
2.
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database.
Curr Oncol
; 28(5): 4213-4222, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677275
3.
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials.
Eur J Cancer
; 151: 115-125, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975059
Resultados
1 -
3
de 3
1
Próxima >
>>